Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-5518
Ahmadi, S; Liebel, J T; Zeilhofer, H U (2001). The role of the ORL1 receptor in the modulation of spinal neurotransmission by nociceptin/orphanin FQ and nocistatin. European Journal of Pharmacology, 412(1):39-44.
| PDF - Registered users only 193Kb |
Abstract
Nociceptin/orphanin FQ and nocistatin are two neuropeptides with opposing effects on spinal neurotransmission and nociception. Nociceptin/orphanin FQ selectively suppresses excitatory glutamatergic neurotransmission, while nocistatin selectively interferes with glycinergic and gamma-aminobutyric acid (GABA)-ergic transmission. Here, we performed whole-cell patch-clamp recordings from superficial rat spinal cord dorsal horn neurons to investigate the role of the opioid receptor-like (ORL)1 receptor for modulatory actions of these peptides. The partial ORL1 receptor antagonist [phe1psi(CH(2)-NH)Gly(2)]nociceptin-(1-13)NH(2) competitively reversed the effects of nociceptin/orphanin FQ on excitatory neurotransmission (estimated pA(2) 6.43), but left the suppression of inhibitory synaptic transmission by nocistatin unaffected. These results indicate that the inhibitory action of nociceptin/orphanin FQ on glutamatergic transmission is mediated via ORL1 receptors, while nocistatin acts via a different so far unidentified receptor.
| Item Type: | Journal Article, refereed, original work |
|---|---|
| Communities & Collections: | 04 Faculty of Medicine > Institute of Pharmacology and Toxicology |
| DDC: | 570 Life sciences; biology 610 Medicine & health |
| Language: | English |
| Date: | 19 January 2001 |
| Deposited On: | 26 Mar 2009 13:34 |
| Last Modified: | 05 Dec 2012 21:21 |
| Publisher: | Elsevier |
| ISSN: | 0014-2999 |
| Publisher DOI: | 10.1016/S0014-2999(00)00946-8 |
| PubMed ID: | 11166734 |
| WoS Citation Count: | 7 |
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page